ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Inovalon Launches Provider Market Insights To Empower Life Sciences Organizations With Superior Market Data

BOWIE, Md., July 23, 2024 (GLOBE NEWSWIRE) -- Inovalon, a leading provider of cloud-based software solutions empowering data-driven healthcare, today launched Provider Market Insights, a SaaS solution leveraging the industry's largest primary source patient dataset to meet the high demand for comprehensive analyses by life sciences organizations across the provider landscape. The solution analyzes life science brands and the performance of competing therapies, evaluates patient demographics, socioeconomics, and insights into disease and management strategies. By combining real-world data covering 97% of active U.S. healthcare providers with advanced analytics, Inovalon’s Provider Market Insights enables life sciences organizations to optimize investments based on market intelligence and accelerate the launch of innovative therapies.

More than one in three of today’s drug launches fail to meet market expectations in their first year due to limited access to market data, inadequate understanding of customer needs, and poor product differentiation. Inovalon’s Provider Market Insights removes these barriers for life sciences teams by providing access to diverse datasets, detailing brand and competitor market activity, and uncovering provider-level insights. This enables organizations to make hyper-targeted, data-first decisions with dynamic and actionable visualizations.

The new software solution analyzes cost drivers and addresses treatment gaps. It also provides data-driven insights to help organizations address social drivers of health (SDOH) impacting patients’ access to care, such as socioeconomic status, environment, and healthcare access, which significantly influence health outcomes, including patients' ability to obtain and adequately use medications.

“Achieving successful drug launches and improving patient access requires a comprehensive understanding of market dynamics and social drivers of health,” said John Chinnici, President and General Manager of Insights at Inovalon. “Our unparalleled data assets position Inovalon to streamline healthcare delivery and overcome barriers to ensure patients receive the most effective and timely treatment available. Provider Market Insights leverages our rich primary source data and analytics to equip life sciences organizations with informative and strategic insights that improve patient outcomes and reduce costs.”

Provider Market Insights, Inovalon's second SaaS solution in its new Commercial Analytics portfolio, offers unparalleled data insights and flexibility to meet customer needs and maximize market impact. Powered by Inovalon’s MORE2 Registry®, the nation’s largest healthcare primary source de-identified dataset, the solution provides insights into individual and organized providers’ market influence, prioritizes customer opportunities based on key performance indicators, and optimizes brand and portfolio investments.

To learn more about Inovalon’s Provider Market Insights, please visit: www.inovalon.com/provider-market-insights.

About Inovalon

Inovalon is a leading provider of cloud-based software solutions empowering data-driven healthcare. The Inovalon ONE® Platform brings together national-scale connectivity, real-time primary source data access, and advanced analytics into a sophisticated cloud-based platform empowering improved outcomes and economics across the healthcare ecosystem. The company’s analytics and capabilities are used by nearly 20,000 customers supporting over 53,000 sites of care, and are informed by the primary source data of more than 84 billion medical events across 1.1 million physicians, 670,000 clinical settings, and 391 million unique lives. For more information, visit www.inovalon.com.

Contact:
Tom Paolella
Sr. Director, Press and Analyst Relations, Inovalon
Thomas.Paolella@inovalon.com


Primary Logo

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.